Dana Investment Advisors, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1427514 BROOKFIELD, WI

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$6,487,858

+$8,010 QoQ

Shares Held

8,397

+0.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

7 quarters on record

Voting authority Sole 90.46087888531619.ToString("F0")% Shared 0.ToString("F0")% None 9.539121114683816.ToString("F0")%

Healthcare · as of Mar 31, 2026

Dana Investment Advisors, Inc. holds $35,335,939 across 12 Biotechnology names. REGN ranks #2 (18.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	69,234	$13,822,568
2	REGN	Regeneron Pharmaceuticals, Inc. This page	8,397	$6,487,858
3	AXSM	Axsome Therapeutics, Inc.	26,379	$4,458,578
4	VKTX	Viking Therapeutics, Inc.	59,756	$1,944,460
5	MDGL	Madrigal Pharmaceuticals, Inc.	3,197	$1,673,533
6	TGTX	Tg Therapeutics, Inc.	43,954	$1,460,151
7	ZYME	Zymeworks Inc.	56,107	$1,404,919
8	IONS	Ionis Pharmaceuticals Inc	18,487	$1,388,188

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,487,858	8,397	+0.0%	Shares	Sole	2026-05-14
2025-12-31	$6,479,848	8,395	+58.0%	Shares	Sole	2026-02-05
2025-09-30	$2,987,340	5,313	+8.5%	Shares	Sole	2025-11-10
2020-12-31	$2,366,272	4,898	-40.2%	Shares	Sole	2021-02-11
2020-09-30	$4,581,799	8,185	-49.2%	Shares	Sole	2020-11-10
2020-06-30	$10,058,227	16,128	-47.1%	Shares	Sole	2020-08-11
2020-03-31	$14,900,169	30,515	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.